Entity Details

Primary name POLG2
Entity type gene
Source Source Link

Details

PrimaryID11232
RefseqGeneNG_013029
SymbolPOLG2
NameDNA polymerase gamma 2, accessory subunit
Chromosome17
Location17q23.3
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1999-09-14
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsDPOG2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001701 in utero embryonic development
GO:0003690 double-stranded DNA binding
GO:0003887 DNA-directed DNA polymerase activity
GO:0005737 cytoplasm
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0005760 gamma DNA polymerase complex
GO:0006261 DNA-dependent DNA replication
GO:0006264 mitochondrial DNA replication
GO:0006281 DNA repair
GO:0007005 mitochondrion organization
GO:0022904 respiratory electron transport chain
GO:0030337 DNA polymerase processivity factor activity
GO:0032042 mitochondrial DNA metabolic process
GO:0042645 mitochondrial nucleoid
GO:0042802 identical protein binding
GO:0070182 DNA polymerase binding
GO:0070584 mitochondrion morphogenesis
GO:1900264 positive regulation of DNA-directed DNA polymerase activity

Diseases

Show/Hide Table
Disease IDSourceNameDescription
610131 OMIMProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4 (PEOA4)A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. The disease is caused by variants affecting the gene represented in this entry.
618528 OMIMMitochondrial DNA depletion syndrome 16, hepatic type (MTDPS16)An autosomal recessive disorder characterized by poor feeding, difficulty breathing, abdominal distention, an abnormal carnitine profile, metabolic acidosis and hepatic failure in the neonatal period. Severe mtDNA depletion is observed in liver and muscle biopsies. The disease may be caused by variants affecting the gene represented in this entry.

Interactions

16 interactions

InteractorPartnerSourcesPublicationsLink
POLG2POLGBioGRID, IntAct, MINT16263719 17762861 19837034 26496610 28514442 details
POLG2POLG2IntAct16263719 details
POLG2PARP1BioGRID24140708 details
POLG2OSBPL1ABioGRID, IntAct26496610 details
POLG2CCDC6BioGRID, IntAct26496610 details
POLG2AP4E1BioGRID, IntAct26496610 details
POLG2STXBP1BioGRID, IntAct26496610 details
POLG2WRAP53BioGRID, IntAct26496610 details
POLG2RPS3BioGRID, IntAct26496610 details
POLG2CLPPBioGRID, IntAct26058080 31056398 details
POLG2IFIT2BioGRID, IntAct28514442 details
POLG2SEC22CBioGRID, IntAct26186194 28514442 details
POLG2HOMER3BioGRID, IntAct28514442 details
POLG2ADNPBioGRID, IntAct28514442 details
POLG2ALDH6A1BioGRID, IntAct28514442 details
POLG2GLDCBioGRID, IntAct28514442 details